All News
Verisk beats third quarter 2026 estimates with 7.4% organic revenue growth and margin expansion
Verisk reported third quarter 2026 results that exceeded analyst estimates on both the top and bottom lines. Growth was primarily fueled by strong subscription...
🔴 ARMG is trading 11.1% down as a ARM-linked ETF
ARMG is trading at $7.65, down 11.1% from a comparison close of $8.61 during pre-market. This product targets about 2x daily exposure to ARM; no separate...
Aclaris Therapeutics narrower third quarter 2026 loss beat estimates as cash runway extends to 2029
Aclaris Therapeutics reported a narrower-than-expected net loss for the third quarter of 2026, driven by disciplined research spending and a gain from the...
BlackSky's Breakout Quarter Rewrites the Growth Story — But Can a Satellite Spy Firm Sustain 118% Revenue Surges?
Shares of BlackSky Technology surged 16.9% to $19.60 after the satellite intelligence company posted third-quarter results that blew past Wall Street...
Shift4 Misses on Revenue and Cuts Guidance Again — How Many Resets Can Investors Stomach Before the Growth Story Unravels?
Shares of Shift4 Payments cratered 16.6% to $37.39 in pre-market trading Thursday after the payments processor reported Q3 net revenue of $648 million, missing...
Ceragon Beats on Every Line and Narrows Its 2026 Outlook — But Can a $200 Million Company Sustain This Momentum?
Shares of Ceragon Networks jumped 9.5% to $2.19 in pre-market trading on November 5 after the Israeli wireless-equipment maker posted third-quarter results...
🟢 YPF is trading 6% up in pre-market
YPF is trading at $44.00, up 5.74% in pre-market, with no verified company-specific catalyst identified. - No verified source explicitly links a November 5...
🟢 XLC is trading 1.85% up in pre-market with no clear catalyst identified
XLC is trading at $106.90, up +1.85%, in pre-market, with no clear XLC-specific catalyst for the November 5 move identified in available news. - A market...
🔴 Vistance Networks (VISN) trading 7.45% down in pre-market after Q3 revenue miss and reduced full-year outlook
Vistance Networks (VISN) is trading 7.45% down at $5.96 in pre-market amid a third-quarter revenue miss and lower full-year outlook. - The company's November...
Akebia Therapeutics third quarter 2026 revenue misses as Vafseo inventory adjustments offset patient growth
Akebia reported third quarter 2026 results that fell short of analyst estimates on both top and bottom lines, as a steep decline in Auryxia sales more than...
Xeris Biopharma's third quarter 2026 revenue of $107M beat estimates by 77% as Recorlev sales surged
Xeris Biopharma reported third quarter 2026 financial results that significantly exceeded consensus expectations, driven by a 93% year-over-year increase in...
Kimbell Royalty Partners third quarter 2026 revenue of $86.3M misses estimates despite record production levels
Kimbell Royalty Partners reported a record operational quarter, although headline financial figures fell short of analyst consensus estimates. The Partnership...
ConocoPhillips beats third quarter 2026 estimates with 2.3 million BOED production and dividend hike
ConocoPhillips delivered third quarter 2026 results that surpassed analyst expectations on both the top and bottom lines. Financial performance was bolstered...
🟢 NovaGold Resources is trading 4.13% up in pre-market after shareholders approved Donlin Gold stake acquisition
NovaGold Resources is trading at $6.35, up 4.13%, after shareholders approved acquisition of Paulson’s remaining 40% Donlin Gold interest. - The arrangement...
Appian beats third quarter 2026 estimates led by 20% cloud subscription revenue growth
Appian delivered a robust third quarter 2026, reporting total revenue of $234.6 million and non-GAAP earnings that significantly outperformed analyst...
🟢 Sunshine Biopharma is trading 8.68% up in pre-market on November 5, 2026 with no clear catalyst
Sunshine Biopharma is trading at $2.88, up 8.68% in pre-market on November 5, 2026, with no definitive catalyst identified. - No new company-specific...
🟢 Sappi is trading 10.16% up — no verified catalyst identified
Sappi is trading 10.16% higher at ZAc 1301.00; no verified report directly attributes the November 5 move to a specific catalyst. - On November 5, Sappi and...
OpenText's first quarter 2027 earnings beat estimates despite a miss in cloud revenue
OpenText reported total revenue of $1.24 billion for the first quarter of fiscal 2027, exceeding analyst estimates of $1.22 billion. While non-GAAP diluted EPS...
🔴 ROOT is trading 10% down in pre-market after Q3 revenue missed estimates
ROOT is trading 10.22% down at $51.31 in pre-market after Q3 revenue of $381.3 million missed estimates, though EPS beat expectations. - Shares are down from...
🟢 Perpetua Resources is trading 5.84% up in pre-market after reporting high-grade gold-antimony drill results
Perpetua Resources is trading at $17.31, up 5.84%, in pre-market after reporting new drilling results at its Stibnite project. - At the Fiddle prospect,...